세계의 말초신경손상 시장 규모 조사 및 예측 : 제품별, 용도별, 수술별, 지역별 분석(2023-2030년)

Global Peripheral Nerve Injuries Market is valued at approximately USD 1.43 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.65% over the forecast period 2023-2030. Peripheral nerve injury includes a broad range of clinical conditions that may present as peripheral nervous system dysfunction. Peripheral nerve injuries are a common condition that can result in a variety of symptoms depending on the severity and nerves affected. Peripheral nerve injuries can cause patients to experience anything from minor discomfort to complete paralysis. Peripheral nerve damage frequently presents with symptoms of weakness, numbness, and discomfort. However, the global peripheral nerve injury therapeutics market is likely to be driven by increased awareness of peripheral nerve injury and its treatment through drugs and therapies to manage the illness. Furthermore, the rising incidence rate of PNIs influences the revenue growth of the treatment market.

The market for peripheral nerve injuries is growing in terms of value due to the rising prevalence of chronic disorders. According to the National Institute of Health, In 2022, peripheral nerve issues impact 2.4% of the population among which 8.0% belongs to the elderly populations. In 2021, it was projected by the International Diabetes Federation that there would be approximately 537 million adults worldwide affected by diabetes, and one out of every ten individuals would also experience other forms of diabetes. Diabetic neuropathy, which is nerve damage associated with both type 1 and type 2 diabetes, affects around 50% of people with these chronic conditions. Peripheral nerve damage from leprosy is still a widespread problem worldwide. Additionally, elderly individuals and those who are obese are more prone to developing chronic illnesses. According to the World Bank Group, the global elderly population stood at 727 million in 2020, and it is expected to triple in the next 30 years, reaching 1.5 billion by 2050. The market's revenue growth is being driven by an increase in research and development activities for focused treatment of peripheral nerve injury as well as the vital requirement for more education for doctors and nurses to enable them to provide prompt diagnoses and appropriate patient care. However, doctors and patients may both still be unaware of the syndrome's prevalence is one of the factors limiting growth. The availability of physical therapy for the disorder's treatment also hinders the market's expansion throughout the forecast period of 2023-2030.

The key regions considered for the Global Peripheral Nerve Injuries Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America is expected to account for the largest revenue share over the forecast period. This is due to the introduction of new treatment options in the region. Furthermore, increased healthcare expenditures, as well as the availability of treatment choices, would help drive revenue growth of peripheral nerve injuries market in the region. Moreover, rising awareness of the disease has led to revenue growth in the market. These factors are expected to drive revenue growth of the peripheral nerve injury market in the region over the forecast period. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the number of elderly people has significantly increased in nations such as China and India. Additionally, the presence of generic drug makers and the expansion of healthcare facilities in the area are key factors in the region's revenue growth.

Major market player included in this report are:

• AxoGen, Inc.
• Stryker
• Baxter International, Inc.
• Polyganics BV
• Integra Lifesciences Corp.
• Renerva, LLC.
• Medovent GmbH
• Toyobo Co., Ltd
• Medtronic plc
• Stryker Corporation

Recent Developments in the Market:

• In March 2022, Integra LifeSciences Holding Corp. announced the release of the 3D Nerve Guide Matrix, also known as NeuraGen, a resorbable implant for the healing of peripheral nerve discontinuities.
• In April 2021, on the Zernike Campus in Groningen, Polyganics, a medical technology company that develops, manufactures, and sells bioresorbable medical devices, constructed a new facility. The facility is designed to support Polyganics' ongoing development, manufacturing, and sales operations, further advancing their innovative medical device solutions.

Global Peripheral Nerve Injuries Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimatio: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Application, Surgery, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Nerve Conduit
• Nerve Protector
• Nerve Connector
• Nerve Wraps

By Application:

• Upper Extremities
• Lower Extremities

By Surgery:

• Direct Nerve Repair
• Nerve Grafting
• Stem Cell Therapy

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Peripheral Nerve Injuries Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Peripheral Nerve Injuries Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Peripheral Nerve Injuries Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Peripheral Nerve Injuries Market, by Surgery, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Peripheral Nerve Injuries Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Peripheral Nerve Injuries Market Dynamics

• 3.1. Peripheral Nerve Injuries Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing Incidence of PNIs
    • 3.1.1.2. Growing awareness of Peripheral nerve injury and its treatment through drugs and therapies
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of Awareness among doctors and patients about Peripheral Nerve Injuries
    • 3.1.2.2. Availability of physical therapy for the disorder's treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising Demand for more education for doctors and nurses to provide prompt diagnoses
    • 3.1.3.2. Increasing research and development activities for focused treatment of peripheral nerve injury

Chapter 4. Global Peripheral Nerve Injuries Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Peripheral Nerve Injuries Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Peripheral Nerve Injuries Market by Product, Performance - Potential Analysis
• 5.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
  • 5.4.1. Nerve Conduit
  • 5.4.2. Nerve Protector
  • 5.4.3. Nerve Connector
  • 5.4.4. Nerve Wraps

Chapter 6. Global Peripheral Nerve Injuries Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Peripheral Nerve Injuries Market by Application, Performance - Potential Analysis
• 6.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
  • 6.4.1. Upper Extremities
  • 6.4.2. Lower Extremities

Chapter 7. Global Peripheral Nerve Injuries Market, by Surgery

• 7.1. Market Snapshot
• 7.2. Global Peripheral Nerve Injuries Market by Surgery, Performance - Potential Analysis
• 7.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Surgery 2020-2030 (USD Billion)
• 7.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
  • 7.4.1. Direct Nerve Repair
  • 7.4.2. Nerve Grafting
  • 7.4.3. Stem Cell Therapy

Chapter 8. Global Peripheral Nerve Injuries Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Peripheral Nerve Injuries Market, Regional Market Snapshot
• 8.4. North America Peripheral Nerve Injuries Market
  • 8.4.1. U.S. Peripheral Nerve Injuries Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Surgery breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Peripheral Nerve Injuries Market
• 8.5. Europe Peripheral Nerve Injuries Market Snapshot
  • 8.5.1. U.K. Peripheral Nerve Injuries Market
  • 8.5.2. Germany Peripheral Nerve Injuries Market
  • 8.5.3. France Peripheral Nerve Injuries Market
  • 8.5.4. Spain Peripheral Nerve Injuries Market
  • 8.5.5. Italy Peripheral Nerve Injuries Market
  • 8.5.6. Rest of Europe Peripheral Nerve Injuries Market
• 8.6. Asia-Pacific Peripheral Nerve Injuries Market Snapshot
  • 8.6.1. China Peripheral Nerve Injuries Market
  • 8.6.2. India Peripheral Nerve Injuries Market
  • 8.6.3. Japan Peripheral Nerve Injuries Market
  • 8.6.4. Australia Peripheral Nerve Injuries Market
  • 8.6.5. South Korea Peripheral Nerve Injuries Market
  • 8.6.6. Rest of Asia Pacific Peripheral Nerve Injuries Market
• 8.7. Latin America Peripheral Nerve Injuries Market Snapshot
  • 8.7.1. Brazil Peripheral Nerve Injuries Market
  • 8.7.2. Mexico Peripheral Nerve Injuries Market
• 8.8. Middle East & Africa Peripheral Nerve Injuries Market
  • 8.8.1. Saudi Arabia Peripheral Nerve Injuries Market
  • 8.8.2. South Africa Peripheral Nerve Injuries Market
  • 8.8.3. Rest of Middle East & Africa Peripheral Nerve Injuries Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. AxoGen, Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Stryker
  • 9.3.3. Baxter International, Inc.
  • 9.3.4. Polyganics BV
  • 9.3.5. Integra Lifesciences Corp.
  • 9.3.6. Renerva, LLC.
  • 9.3.7. Medovent GmbH
  • 9.3.8. Toyobo Co., Ltd
  • 9.3.9. Medtronic plc
  • 9.3.10. Stryker Corporation

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption